ResearcherThe University of Texas MD Anderson Cancer CenterActive in the last 2 years
Ching-Fei Li
Matched on ORCID iD 0000-0001-7844-7003; OpenAlex author ID A5017849151. Sources: OpenAlex.
Their work
- Papers
- 5
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 32
2024: 2 papers · 2025: 1 paper · 2026: 2 papers
Papers 5
- All-trans retinoic acid destabilizes ADAR1 protein through retinoylation-mediated USP7 dissociation and improves immunotherapy in pancreatic cancer. Co-author DOI 10.1038/s41467-026-72271-5↗
- The Lysine Demethylase KDM4C Is an Oncogenic Driver and Regulates ERK Activity in KRAS-Mutant Pancreatic Ductal Adenocarcinoma. Co-author DOI 10.1158/2767-9764.crc-25-0278↗
- KRAS Inhibition Activates an Actionable CD24 "Do Not Eat Me" Signal in Pancreatic Cancer. Co-author DOI 10.1158/0008-5472.can-25-2024↗
- Nardilysin-regulated scission mechanism activates polo-like kinase 3 to suppress the development of pancreatic cancer. Co-author DOI 10.1038/s41467-024-47242-3↗
- All-trans retinoic acid-mediated ADAR1 degradation synergizes with PD-1 blockade to suppress pancreatic cancer Co-author DOI 10.1101/2024.10.20.619300↗
Closest collaborators
The 25 strongest of 32 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Haoqiang Ying · 4 shared papers, 2024–2026 · strength 0.81
- Paper The Lysine Demethylase KDM4C Is an Oncogenic Driver and Regulates ERK Activity in KRAS-Mutant Pancreatic Ductal Adenoca… DOI 10.1158/2767-9764.crc-25-0278↗
- Paper All-trans retinoic acid destabilizes ADAR1 protein through retinoylation-mediated USP7 dissociation and improves immuno… DOI 10.1038/s41467-026-72271-5↗
- Paper KRAS Inhibition Activates an Actionable CD24 "Do Not Eat Me" Signal in Pancreatic Cancer. DOI 10.1158/0008-5472.can-25-2024↗
- Huamin Wang · 4 shared papers, 2024–2026 · strength 0.79
- Paper The Lysine Demethylase KDM4C Is an Oncogenic Driver and Regulates ERK Activity in KRAS-Mutant Pancreatic Ductal Adenoca… DOI 10.1158/2767-9764.crc-25-0278↗
- Paper All-trans retinoic acid destabilizes ADAR1 protein through retinoylation-mediated USP7 dissociation and improves immuno… DOI 10.1038/s41467-026-72271-5↗
- Paper KRAS Inhibition Activates an Actionable CD24 "Do Not Eat Me" Signal in Pancreatic Cancer. DOI 10.1158/0008-5472.can-25-2024↗
- Anirban Maitra · 4 shared papers, 2024–2026 · strength 0.78
- Paper The Lysine Demethylase KDM4C Is an Oncogenic Driver and Regulates ERK Activity in KRAS-Mutant Pancreatic Ductal Adenoca… DOI 10.1158/2767-9764.crc-25-0278↗
- Paper All-trans retinoic acid destabilizes ADAR1 protein through retinoylation-mediated USP7 dissociation and improves immuno… DOI 10.1038/s41467-026-72271-5↗
- Paper All-trans retinoic acid-mediated ADAR1 degradation synergizes with PD-1 blockade to suppress pancreatic cancer DOI 10.1101/2024.10.20.619300↗
- Yongkun Wei · 3 shared papers, 2024–2026 · strength 0.54
- Paper All-trans retinoic acid destabilizes ADAR1 protein through retinoylation-mediated USP7 dissociation and improves immuno… DOI 10.1038/s41467-026-72271-5↗
- Paper KRAS Inhibition Activates an Actionable CD24 "Do Not Eat Me" Signal in Pancreatic Cancer. DOI 10.1158/0008-5472.can-25-2024↗
- Paper All-trans retinoic acid-mediated ADAR1 degradation synergizes with PD-1 blockade to suppress pancreatic cancer DOI 10.1101/2024.10.20.619300↗
- Jianhua Ling · 3 shared papers, 2024–2026 · strength 0.51
- Paper All-trans retinoic acid destabilizes ADAR1 protein through retinoylation-mediated USP7 dissociation and improves immuno… DOI 10.1038/s41467-026-72271-5↗
- Paper All-trans retinoic acid-mediated ADAR1 degradation synergizes with PD-1 blockade to suppress pancreatic cancer DOI 10.1101/2024.10.20.619300↗
- Paper Nardilysin-regulated scission mechanism activates polo-like kinase 3 to suppress the development of pancreatic cancer. DOI 10.1038/s41467-024-47242-3↗
- Jie Fu · 3 shared papers, 2024–2026 · strength 0.51
- Paper All-trans retinoic acid destabilizes ADAR1 protein through retinoylation-mediated USP7 dissociation and improves immuno… DOI 10.1038/s41467-026-72271-5↗
- Paper All-trans retinoic acid-mediated ADAR1 degradation synergizes with PD-1 blockade to suppress pancreatic cancer DOI 10.1101/2024.10.20.619300↗
- Paper Nardilysin-regulated scission mechanism activates polo-like kinase 3 to suppress the development of pancreatic cancer. DOI 10.1038/s41467-024-47242-3↗
- Paul J. Chiao · 3 shared papers, 2024–2026 · strength 0.51
- Paper All-trans retinoic acid destabilizes ADAR1 protein through retinoylation-mediated USP7 dissociation and improves immuno… DOI 10.1038/s41467-026-72271-5↗
- Paper All-trans retinoic acid-mediated ADAR1 degradation synergizes with PD-1 blockade to suppress pancreatic cancer DOI 10.1101/2024.10.20.619300↗
- Paper Nardilysin-regulated scission mechanism activates polo-like kinase 3 to suppress the development of pancreatic cancer. DOI 10.1038/s41467-024-47242-3↗
- Mien‐Chie Hung · 3 shared papers, 2024–2026 · strength 0.51
- Paper All-trans retinoic acid destabilizes ADAR1 protein through retinoylation-mediated USP7 dissociation and improves immuno… DOI 10.1038/s41467-026-72271-5↗
- Paper All-trans retinoic acid-mediated ADAR1 degradation synergizes with PD-1 blockade to suppress pancreatic cancer DOI 10.1101/2024.10.20.619300↗
- Paper Nardilysin-regulated scission mechanism activates polo-like kinase 3 to suppress the development of pancreatic cancer. DOI 10.1038/s41467-024-47242-3↗
- Wantong Yao · 2 shared papers, 2025–2026 · strength 0.38
- Ying‐Nai Wang · 2 shared papers, 2024–2026 · strength 0.37
- Paper All-trans retinoic acid destabilizes ADAR1 protein through retinoylation-mediated USP7 dissociation and improves immuno… DOI 10.1038/s41467-026-72271-5↗
- Paper All-trans retinoic acid-mediated ADAR1 degradation synergizes with PD-1 blockade to suppress pancreatic cancer DOI 10.1101/2024.10.20.619300↗
- Li‐Yuan Bai · 2 shared papers, 2024–2026 · strength 0.37
- Paper All-trans retinoic acid destabilizes ADAR1 protein through retinoylation-mediated USP7 dissociation and improves immuno… DOI 10.1038/s41467-026-72271-5↗
- Paper All-trans retinoic acid-mediated ADAR1 degradation synergizes with PD-1 blockade to suppress pancreatic cancer DOI 10.1101/2024.10.20.619300↗
- Dihua Yu · 2 shared papers, 2024–2026 · strength 0.37
- Paper All-trans retinoic acid destabilizes ADAR1 protein through retinoylation-mediated USP7 dissociation and improves immuno… DOI 10.1038/s41467-026-72271-5↗
- Paper All-trans retinoic acid-mediated ADAR1 degradation synergizes with PD-1 blockade to suppress pancreatic cancer DOI 10.1101/2024.10.20.619300↗
- Jun Yao · 2 shared papers, 2024–2025 · strength 0.32
- MennatAllah Shaheen · 1 shared paper, 2026 · strength 0.27
- Benson Chellakkan Selvanesan · 1 shared paper, 2026 · strength 0.27
- Bidyut Ghosh · 1 shared paper, 2026 · strength 0.27
- Cheng‐Wei Chou · 1 shared paper, 2026 · strength 0.21
- Andrea Viale · 1 shared paper, 2025 · strength 0.17
- Dan Zhao · 1 shared paper, 2025 · strength 0.17
- Abdelrahman M.G. Yousef · 1 shared paper, 2025 · strength 0.17
- Hong Zhao · 1 shared paper, 2025 · strength 0.17
- Timothy Paul Heffernan · 1 shared paper, 2025 · strength 0.17
- Ronald Anthony Depinho · 1 shared paper, 2025 · strength 0.17
- Ping Chen · 1 shared paper, 2024 · strength 0.14
- Ya’an Kang · 1 shared paper, 2024 · strength 0.14
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.